» Articles » PMID: 29778516

Facilitators of and Barriers to HPV Vaccination Among Sexual and Gender Minority Patients at a Boston Community Health Center

Overview
Journal Vaccine
Date 2018 May 21
PMID 29778516
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Young sexual minority individuals have lower human papillomavirus (HPV) vaccine completion rates than the general population, and little is known about how gender minority people perceive HPV vaccination. The aim of this study was to qualitatively identify patient-, provider-, and systems-level barriers and facilitators for HPV vaccination among sexual and gender minority (SGM) people.

Methods: Fifteen SGM-identified individuals, ages 23-26, were recruited at an urban community health center in Boston, MA, that specializes in care for SGM. Participants were enrolled in a study that utilized surveys and in-person focus groups. During focus groups, participants were asked to describe their perceived barriers and facilitators for completion of HPV vaccination.

Results: Fourteen participants reported having a sexual minority identity, and five participants reported having a gender minority identity. Participants described the following factors influencing HPV vaccination: (1) at the patient level, low HPV-related knowledge and lack of engagement in care were associated with less vaccination, whereas fear of HPV-related disease motivated vaccination; (2) at the provider level, knowledge and SGM cultural-competence related to HPV was associated with patient willingness to be vaccinated; (3) at the systems level, SGM identity-affirming healthcare settings were associated with increased vaccination, whereas historical trends in HPV vaccine marketing selectively for cisgender women and lack of public awareness of HPV-related disease among SGM were associated with decreased vaccincation.

Conclusion: Our study identified internal and external barriers for HPV vaccination related among SGM patients. These findings highlight the need to increase public awareness about the risks of HPV-related disease among SGM and educate SGM youth about HPV-related disease and vaccine importance. Finally, this study supports the need for future interventions to cultivate SGM-competent providers and SGM identity-affirming healthcare settings as a way to increase HPV vaccination.

Citing Articles

HPV Vaccine Awareness and Uptake Among Sexually Transmitted Infections Clinic Users: A Cross-Sectional Study in Bologna, Italy.

Cleva M, Gaspari V, Ceccarelli A, Pianese G, Griffa D, Orioni G Int J Environ Res Public Health. 2024; 21(11).

PMID: 39595782 PMC: 11593965. DOI: 10.3390/ijerph21111515.


"Why Not Just go on PrEP?": A Study to Inform Implementation of an HIV Prevention Intervention Among Hispanic/Latino Men Who Have Sex With Men in the Northeastern United States.

Rogers B, Toma E, Harkness A, Arnold T, Nagel K, Bajic J J Acquir Immune Defic Syndr. 2024; 97(1):26-39.

PMID: 39116329 PMC: 11434228. DOI: 10.1097/QAI.0000000000003461.


Socioeconomic inequalities in human papillomavirus knowledge and vaccine uptake: evidence from a cross-sectional study in China.

Gong X, Xu J, He Y, Zou G, Liu J Front Public Health. 2024; 12:1399192.

PMID: 38993697 PMC: 11236539. DOI: 10.3389/fpubh.2024.1399192.


Predictors of parental acceptance to live attenuated influenza vaccine for children.

Qu S, Zhou M, Campy K, He W Hum Vaccin Immunother. 2024; 20(1):2356343.

PMID: 38835204 PMC: 11155699. DOI: 10.1080/21645515.2024.2356343.


Facilitators and Barriers of HPV Vaccine Acceptance, Initiation, and Completion among LGBTQ Community in the U.S.: A Systematic Review.

Hao Z, Guo Y, Bowling J, Ledenyi M Int J Sex Health. 2024; 34(2):291-307.

PMID: 38596525 PMC: 10903696. DOI: 10.1080/19317611.2021.1989535.


References
1.
Markowitz L, Dunne E, Saraiya M, Chesson H, Curtis C, Gee J . Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63(RR-05):1-30. View

2.
Fenkl E, Schochet E, Jones S, da Costa B . Evaluation of an HPV/Anal Cancer Screening Awareness Program for HIV-infected Men Who Have Sex With Men. J Assoc Nurses AIDS Care. 2015; 26(4):492-7. DOI: 10.1016/j.jana.2015.01.003. View

3.
Westerstahl A, Segesten K, Bjorkelund C . GPs and lesbian women in the consultation: issues of awareness and knowledge. Scand J Prim Health Care. 2003; 20(4):203-7. DOI: 10.1080/028134302321004845. View

4.
Gilkey M, Calo W, Moss J, Shah P, Marciniak M, Brewer N . Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine. 2016; 34(9):1187-92. PMC: 4944755. DOI: 10.1016/j.vaccine.2016.01.023. View

5.
Brewer N, Ng T, McRee A, Reiter P . Men's beliefs about HPV-related disease. J Behav Med. 2010; 33(4):274-81. PMC: 4018629. DOI: 10.1007/s10865-010-9251-2. View